BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1019 related articles for article (PubMed ID: 18819934)

  • 61. Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors.
    Mohanam S; Gladson CL; Rao CN; Rao JS
    Front Biosci; 1999 Feb; 4():D178-87. PubMed ID: 9989951
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin.
    Iwamoto J; Takahashi K; Mizokami Y; Otsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokoube K; Matsuoka T
    Dig Dis Sci; 2003 Dec; 48(12):2247-56. PubMed ID: 14714609
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development.
    Li M; Karakji EG; Xing R; Fryer JN; Carnegie JA; Rabbani SA; Tsang BK
    Endocrinology; 1997 Jul; 138(7):2790-9. PubMed ID: 9202219
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D; Berger DH; Rothman VL; Tuszynski GP
    J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role.
    Plebani M; Herszènyi L; Carraro P; De Paoli M; Roveroni G; Cardin R; Tulassay Z; Naccarato R; Farinati F
    Clin Exp Metastasis; 1997 Jul; 15(4):418-25. PubMed ID: 9219730
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells.
    Hirashima Y; Kobayashi H; Suzuki M; Tanaka Y; Kanayama N; Terao T
    J Biol Chem; 2003 Jul; 278(29):26793-802. PubMed ID: 12743121
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Plasminogen activation in venous leg ulcers.
    Herouy Y; Trefzer D; Hellstern MO; Stark GB; Vanscheidt W; Schöpf E; Norgauer J
    Br J Dermatol; 2000 Nov; 143(5):930-6. PubMed ID: 11069499
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hyperglycemia impairs cytotrophoblast function via stress signaling.
    Cawyer CR; Horvat D; Leonard D; Allen SR; Jones RO; Zawieja DC; Kuehl TJ; Uddin MN
    Am J Obstet Gynecol; 2014 Nov; 211(5):541.e1-8. PubMed ID: 24793974
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
    Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1).
    Borgfeldt C; Hansson SR; Gustavsson B; Måsbäck A; Casslén B
    Int J Cancer; 2001 May; 92(4):497-502. PubMed ID: 11304683
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.
    Planus E; Barlovatz-Meimon G; Rogers RA; Bonavaud S; Ingber DE; Wang N
    J Cell Sci; 1997 May; 110 ( Pt 9)():1091-8. PubMed ID: 9175705
    [TBL] [Abstract][Full Text] [Related]  

  • 73. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
    Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
    Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
    Lundgren CH; Sawa H; Sobel BE; Fujii S
    Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
    Kaneko T; Konno H; Baba M; Tanaka T; Nakamura S
    Cancer Sci; 2003 Jan; 94(1):43-9. PubMed ID: 12708473
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.
    Tran H; Maurer F; Nagamine Y
    Mol Cell Biol; 2003 Oct; 23(20):7177-88. PubMed ID: 14517288
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor.
    Li H; Kuo A; Kochan J; Strickland D; Kariko K; Barnathan ES; Cines DB
    J Biol Chem; 1994 Mar; 269(11):8153-8. PubMed ID: 7510679
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells.
    Iwaki S; Yamamura S; Asai M; Sobel BE; Fujii S
    Biochim Biophys Acta; 2012; 1819(11-12):1132-41. PubMed ID: 22819712
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sphingosine-1-phosphate differently regulates the cytokine production of IL-12, IL-23 and IL-27 in activated murine bone marrow derived dendritic cells.
    Schaper K; Kietzmann M; Bäumer W
    Mol Immunol; 2014 May; 59(1):10-8. PubMed ID: 24434636
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.